<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04250476645489</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33546-V</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.730Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645502</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33548-V</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.716Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645526</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN34-AKZ-MG-LL1</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.704Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645540</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN34-AKZ-MG-M01</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.687Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645564</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN34-AKZ-MG-S01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.673Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645588</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN34-AKZ-MG-XS1</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.658Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645700</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN56-AKZ-PH-S01</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.646Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645724</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN56-AKZ-PH-M01</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.630Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645885</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>LATEX EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLODL29-AKZ-WH-LL1</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.615Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645908</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>LATEX EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLODL29-AKZ-WH-M01</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.600Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645922</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>LATEX EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLODL29-AKZ-WH-S01</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.585Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645946</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>LATEX EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLODL29-AKZ-WH-XS1</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.571Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476646066</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>PURE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>231787</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.557Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476646080</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>PURE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>231786</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.537Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476646103</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>PURE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>231785</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.521Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476646127</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>PURE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>231784</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.511Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476646141</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33542-B</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.495Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476646165</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33544-B</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.485Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476646189</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33546-B</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.471Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476646202</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33548-B</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.462Z</lastUpdated>
  </row>
</eudamedExport>